Building Confidence: Assura Reports Solid Q3 Progress

Photo of author

By Callum Scott

 

Credit: Assura

Assura PLC, a leading UK based healthcare real estate investment trust, has reported steady progress in the third quarter ending December 31, 2024. The company continues to enhance its portfolio and maintain a stable dividend, reinforcing its position in the healthcare infrastructure sector.

Portfolio Enhancements and Capital Recycling

During Q3, Assura completed the sale of 17 properties, raising £48 million. This strategic move is part of the company’s ongoing capital recycling program aimed at optimizing its portfolio and funding future growth. Discussions are underway for additional disposals totaling £110 million, with a further £90 million identified for potential sale.

The proceeds from these disposals have contributed to a £46 million reduction in net debt, aligning with Assura’s target to achieve a net debt to EBITDA ratio below nine times and a loan to value ratio below 45% over the next 12 to 18 months.

Dividend 

Assura has maintained its quarterly dividend at 0.84 pence per share, reflecting the company’s commitment to providing consistent returns to shareholders. This equates to an annualized dividend of 3.36 pence per share, offering an attractive yield for income focused investors.

Development Projects and Rent Reviews

The company is actively engaged in development projects, with five currently underway totaling £44 million. Two of these projects are net zero carbon buildings in the UK, expected to become fully rent producing in the next quarter.

Assura completed rent reviews on 59 leases during the quarter, resulting in a 7.2% uplift worth £600,000. This demonstrates the company’s ability to generate incremental income through effective lease management.

Strategic Positioning in Healthcare Infrastructure

Chief Executive Officer Jonathan Murphy emphasized Assura’s role in addressing the UK’s growing demand for improved healthcare infrastructure. He highlighted recent policy actions, including £900 million of funding for GPs announced in December and an additional £100 million committed to upgrading the GP estate. Murphy stated, Assura is uniquely positioned to support this shift through the delivery of high quality, modern, and sustainable facilities.

Assura’s strategic moves, including portfolio optimization, development of sustainable healthcare facilities, and good financial management, position the company well for continued growth. The focus on capital recycling and maintaining a strong balance sheet shows its commitment to delivering value to shareholders while supporting the evolving needs of the UK’s healthcare sector.


Content on IceburgWealth.com is for informational purposes only and not intended as investment advice. While we strive to provide accurate and up-to-date information, Iceburg Wealth is not responsible for any errors or omissions, or for outcomes resulting from the use of this information. Readers should seek professional advice before making any financial decisions.

Leave a comment